Oncology Specialist | Associate Chief Physician

Dr. Wang Baoli is an experienced oncology specialist with nearly 20 years of clinical practice in China’s leading Grade A tertiary hospitals. He is recognized for his expertise in precision oncology, minimally invasive cancer therapies, and personalized multidisciplinary treatment strategies.

Areas of Expertise

Dr. Wang specializes in the diagnosis and treatment of various complex cancers, including:

• Lung Cancer
• Liver Cancer
• Colon Cancer
• Gastric Cancer
• Esophageal Cancer
• Ovarian Cancer
• Cervical Cancer

His clinical expertise covers:

• Precision minimally invasive interventional therapy
• Chemotherapy
• Targeted therapy and immunotherapy combinations
• Individualized cancer treatment planning through the Multidisciplinary Team (MDT) approach

By integrating molecular pathology analysis with advanced oncology techniques, Dr. Wang focuses on improving treatment effectiveness while enhancing patients’ quality of life.

Professional Memberships

Dr. Wang actively contributes to several professional oncology and medical organizations, including:

• Member of the Hepatobiliary and Pancreatic Tumors Professional Committee, Guangzhou Anti-Cancer Association
• Member of the Tumor Immunotherapy Professional Committee, Guangdong Pharmaceutical Association
• Member of the Interventional Medicine Professional Committee, Guangzhou Medical Association
• Member of the Liver Cancer Professional Committee, Chinese Geriatrics Society
• Member of the Thyroid Nodule and Tumor Prevention and Control Professional Committee, China Health Care Association

Academic Achievements & Research

Dr. Wang has made significant contributions to clinical oncology research and academic development.

Publications

• Published 5 papers in leading core medical journals
• Published 1 SCI-indexed international research paper

Awards & Recognition

• Third Prize for Military Medical Achievements (2014) for research on Nedaplatin in advanced nasopharyngeal carcinoma
• Third Prize in the International Journal of Oncology Essay Contest (2013)

Research Focus

His research primarily focuses on:

• Integrated minimally invasive cancer therapy
• MDT-based precision diagnosis and treatment
• Combined targeted therapy and immunotherapy strategies

Selected Research Papers

• Treatment of Mid-late Stage NSCLC Using Sodium Cantharidinate/Vitamin B6/GP Regimen in Clinic — published in the Journal of Cancer Research and Therapeutics
• Clinical research on Sodium Cantharidinate/Vitamin B6 Injection combined with GP Regimen for mid-to-late stage lung cancer treatment